FDA Approves New Treatment for Squamous Cell Carcinoma
Libtayo is the sixth FDA-approved immune checkpoint inhibitor targeting the PD-1 pathway
WHO: ‘Very High Risk’ That Ebola Will Spread From Congo
Agency says two cases of the deadly virus were confirmed near the border with Uganda
First Human Case of Rat Strain of Hepatitis E Seen in Hong Kong
Infection identified in 56-year-old man who had received a liver transplant in May 2017
Insufficient Sleep Tied to Unsafe Behaviors in High School Students
Sleeping less than eight hours on average school night linked to increased odds of unsafe behaviors
Intravitreal Triamcinolone Beats Periocular Tx for Macular Edema
Intravitreal triamcinolone acetonide, dexamethasone implant best for uveitic macular edema
Hospital Privacy Curtains Become Increasingly Contaminated
Ten to 14 days after being hung, curtains show increased MRSA positivity
Risk of Relapse Up for Teens, Young Adults With Leukemia
Increased risk of on-therapy relapse, relapse after completing therapy versus children with ALL
More Non-Elderly Americans Uninsured in 2017 Versus 2016
More than 700,000 Americans uninsured in 2017 versus 2016, despite broad economic improvement
Factors Associated With Phantom Odor Identified
NIH study shows 6.5 percent of U.S. adults aged 40 and up perceive phantom smells
Mental Health Disparities ID’d Among Students of Color
Variation in symptom prevalence across race, ethnicity; treatment use lower in students of color